Neurexin1 deletion impacts insulin signaling and glucose metabolism in the prefrontal cortex. Researchers say increasing insulin signaling may be an effective therapeutic strategy for the treatment of ASD.
Neurexin1 deletion impacts insulin signaling and glucose metabolism in the prefrontal cortex. Researchers say increasing insulin signaling may be an effective therapeutic strategy for the treatment of ASD.